Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area

BackgroundPentavalent antimonials (PAs) are the primary therapeutic option for American tegumentary leishmaniasis (ATL). However, the use of these drugs is complicated by adverse events (AEs), resistance and contraindications. Alternative therapies relative effectiveness is not well established.Obje...

詳細記述

書誌詳細

出版年:	Frontiers in Cellular and Infection Microbiology
主要な著者:	Daniel Holanda Barroso, Renata Trindade Gonçalves, Joadyson Silva Barbosa, Jorgeth de Oliveira Carneiro da Motta, Gustavo Subtil Magalhães Freire, Ciro Martins Gomes, Raimunda Nonata Ribeiro Sampaio
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2022-09-01
主題:	therapy liposomal amphotericin B (LAB) N-methyl glucamine antimoniate adverse effect American cutaneous leishmaniasis (ACL) mucosal leishmaniasis
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.993338/full